Loading stock data…
CVS
$82.09-1.20 (-1.44%)
Market ClosedLast close May 1
CVS Health Corporation provides health solutions in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CVS Health Corporation in the Healthcare sector is trading at $82.09. The stock is currently near its 52-week high of $85.15, remaining 10.4% above its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why CVS maintains its current momentum and trend strength. The Whystock Score of 85/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 62) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$82.09
Potential Downside
65.8%
Whystock Fair Value$28.11
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus26 analysts
Mean target$96.58+17.6%
Range$79.00 – $140.00
Fundamentals
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$99.93B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
56.09
Beta
Defensive asset. Lower volatility than the S&P 500.
0.51
Div Yield
Strong income play. Yield provides a meaningful total return floor.
348.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.02%
Volume
Today's trading volume
3.82M
Recent News
Drugmakers petition Supreme Court to restore mifepristone mail-order access
Investing.com -- Danco Laboratories and GenBioPro have filed emergency applications with the U.S. Supreme Court seeking to reinstate mail-order access to the abortion pill mifepristone, as first reported by Reuters.
Jim Cramer Makes Major Claim About CVS Corporation (CVS)
We have recently shared Jim Cramer Made A Big Prediction About OpenAI & Discussed These 20 Stocks. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. Pharmaceutical retailer CVS Health Corporation (NYSE:CVS) is one of Jim Cramer’s favorite stocks in the space. The shares are up by roughly 25% over the […]
Court halts mail-order abortion pills as Louisiana legal challenge escalates
Investing.com -- Abortion access in the United States was dealt a legal blow on Friday after a Federal Appeals Court issued a temporary stay halting the distribution of Mifepristone by mail.
CVS Health (CVS) Stock Slides as Market Rises: Facts to Know Before You Trade
In the closing of the recent trading day, CVS Health (CVS) stood at $82.44, denoting a -1.03% move from the preceding trading day.
CVS Health (CVS) Is Up 5.6% After Regulatory Tailwinds Boost Aetna And PBM Visibility – Has The Bull Case Changed?
In recent weeks, CVS Health has reported regulatory and earnings updates, including reaffirmed 2026 adjusted earnings guidance and Medicare Advantage payment changes expected to benefit its Aetna unit, while options activity and analyst commentary point to heightened investor focus on the company’s outlook. Together with reduced regulatory uncertainty around insulin pricing for its Pharmacy Benefit Manager business, these developments highlight how policy decisions can materially influence...